• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

G9U:GR

0.567 EUR 0.0000.00%

As of 02:15:48 ET on 10/01/2014.

Snapshot for TiGenix NV (G9U)

Open: 0.567 Day's Range: 0.540 - 0.581 Volume: 0
Previous Close: 0.567 52wk Range: 0.189 - 1.007 1-Yr Rtn: +200.00%

Stock Chart for G9U

No chart data available.
  • G9U:GR 0.567
  • 1D
  • 1M
  • 1Y
0.567
Interactive G9U Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for G9U

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) -0.1030
Est. PEG Ratio -
Market Cap (M EUR) 90.99
Shares Outstanding (M) 160.48
30 Day Average Volume 116
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/10/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for G9U

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for G9U

TiGenix N.V. is a biomedical company focused on cell therapy. The Company researches and develops treatments for autoimmune and inflammatory diseases.

Eduardo Bravo Fernandez De AraozCEO/Managing DirectorClaudia D AugustaCFO/Secy/Compliance Officer
Wilfried DalemansChief Technology OfficerMarie Paule RichardChief Medical Officer
More Company Profile & Key Executives for G9U

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil